These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25679296)

  • 21. Low Plasma Levels of Fibroblast Growth Factor-21 in Patients with Peripheral Artery Disease.
    Miyazaki Y; Saita E; Kishimoto Y; Ibe S; Seki T; Miura K; Suzuki-Sugihara N; Ikegami Y; Ohmori R; Kondo K; Momiyama Y
    J Atheroscler Thromb; 2018 Sep; 25(9):821-828. PubMed ID: 29367522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast growth factor 23 is associated with the presence of coronary artery disease and the number of stenotic vessels.
    Hu X; Ma X; Pan X; Hao Y; Luo Y; Lu Z; Bao Y; Jia W
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1152-7. PubMed ID: 26217893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients.
    Kirkpantur A; Altun B; Hazirolan T; Akata D; Arici M; Kirazli S; Turgan C
    Artif Organs; 2009 Oct; 33(10):844-54. PubMed ID: 19681840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between fetuin-A and prognosis of CAD: A systematic review and meta-analysis.
    Xie WM; Ran LS; Jiang J; Chen YS; Ji HY; Quan XQ
    Eur J Clin Invest; 2019 May; 49(5):e13091. PubMed ID: 30793296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of serum fibroblast growth factor-23, matrix Gla protein and Fetuin-A in predicting osteoporosis in maintenance hemodialysis patients.
    Wu Q; Xiao DM; Fan WF; Ye XW; Niu JY; Gu Y
    Ther Apher Dial; 2014 Oct; 18(5):427-33. PubMed ID: 25196492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does coronary CT angiography improve risk stratification over coronary calcium scoring in symptomatic patients with suspected coronary artery disease? Results from the prospective multicenter international CONFIRM registry.
    Al-Mallah MH; Qureshi W; Lin FY; Achenbach S; Berman DS; Budoff MJ; Callister TQ; Chang HJ; Cademartiri F; Chinnaiyan K; Chow BJ; Cheng VY; Delago A; Gomez M; Hadamitzky M; Hausleiter J; Kaufmann PA; Leipsic J; Maffei E; Raff G; Shaw LJ; Villines TC; Cury RC; Feuchtner G; Plank F; Kim YJ; Dunning AM; Min JK
    Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):267-74. PubMed ID: 23966421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factor profiling and study of atherosclerotic coronary plaque burden and morphology with coronary computed tomography angiography in coronary artery disease among young Indians.
    Chaudhary R; Chauhan A; Singhal M; Bagga S
    Int J Cardiol; 2017 Aug; 240():452-457. PubMed ID: 28477962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.
    Parker BD; Schurgers LJ; Brandenburg VM; Christenson RH; Vermeer C; Ketteler M; Shlipak MG; Whooley MA; Ix JH
    Ann Intern Med; 2010 May; 152(10):640-8. PubMed ID: 20479029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Sensitivity Troponins Discriminate Different Morphologies of Coronary Artery Plaques Being Assessed by Coronary Computed Tomography Angiography.
    Rusnak J; Behnes M; Reckord N; Hoffmann U; Natale M; Hoffmann J; Weidner K; Lang S; Mukherji A; Kruska M; Henzler T; Schoenberg SO; Borggrefe M; Bertsch T; Akin I
    Dis Markers; 2017; 2017():9306409. PubMed ID: 28804199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of coronary artery plaque composition to coronary artery stenosis severity: results from the prospective multicenter ACCURACY trial.
    Min JK; Edwardes M; Lin FY; Labounty T; Weinsaft JW; Choi JH; Delago A; Shaw LJ; Berman DS; Budoff MJ
    Atherosclerosis; 2011 Dec; 219(2):573-8. PubMed ID: 21696739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel serum biomarkers in carotid artery stenosis: useful to identify the vulnerable plaque?
    Hermus L; Schuitemaker JH; Tio RA; Breek JC; Slart RH; de Boef E; Zeebregts CJ
    Clin Biochem; 2011 Nov; 44(16):1292-8. PubMed ID: 21939648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of aerobic versus resistance training on serum fetuin-A, fetuin-B, and fibroblast growth factor-21 levels in male diabetic patients.
    Keihanian A; Arazi H; Kargarfard M
    Physiol Int; 2019 Mar; 106(1):70-80. PubMed ID: 30888221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum macrophage migration inhibitory factor levels are associated with angiographically complex coronary lesions in patients with coronary artery disease.
    Hao Y; Yi SL; Zhong JQ
    Genet Test Mol Biomarkers; 2015 Oct; 19(10):556-60. PubMed ID: 26263432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals.
    Fitch KV; DeFilippi C; Christenson R; Srinivasa S; Lee H; Lo J; Lu MT; Wong K; Petrow E; Sanchez L; Looby SE; Hoffmann U; Zanni M; Grinspoon SK
    AIDS; 2016 Sep; 30(14):2205-14. PubMed ID: 27314177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetuin-A is associated with calcified coronary artery disease.
    Mori K; Ikari Y; Jono S; Emoto M; Shioi A; Koyama H; Shoji T; Ishimura E; Inaba M; Hara K; Nishizawa Y
    Coron Artery Dis; 2010 Aug; 21(5):281-5. PubMed ID: 20436350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined Assessment of High-Sensitivity Troponin T and Noninvasive Coronary Plaque Composition for the Prediction of Cardiac Outcomes.
    Gitsioudis G; Schüssler A; Nagy E; Maurovich-Horvat P; Buss SJ; Voss A; Hosch W; Hofmann N; Kauczor HU; Giannitsis E; Katus HA; Korosoglou G
    Radiology; 2015 Jul; 276(1):73-81. PubMed ID: 25734549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients.
    Turan MN; Kircelli F; Yaprak M; Sisman AR; Gungor O; Bayraktaroglu S; Ozkahya M; Asci G; Floege J; Ok E
    Int Urol Nephrol; 2016 Apr; 48(4):609-17. PubMed ID: 26865177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac Changes and Their Association with Fetuin-A and Fibroblast Growth Factor-23 in Children with Chronic Kidney Disease.
    Mudi A; Ntsinjana H; Dickens C; Levy C; Ballot D
    Nephron; 2017; 136(3):233-242. PubMed ID: 28402974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower Plasma Fetuin-A Levels Are Associated With a Higher Mortality Risk in Patients With Coronary Artery Disease.
    Chen X; Zhang Y; Chen Q; Li Q; Li Y; Ling W
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2213-2219. PubMed ID: 28912366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma lipidomic analysis predicts non-calcified coronary artery plaque in asymptomatic patients at intermediate risk of coronary artery disease.
    Ellims AH; Wong G; Weir JM; Lew P; Meikle PJ; Taylor AJ
    Eur Heart J Cardiovasc Imaging; 2014 Aug; 15(8):908-16. PubMed ID: 24618657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.